Prof MacCabe will co-lead the Clinical Academic Group, which brings together psychosis researchers, academics, and clinical staff.
A new blood testing solution monitoring treatment for patients with schizophrenia reduces result waiting time from days to minutes.
Researchers discover lower levels of a protein in the connections between neurons in the living brains of people with schizophrenia.
A new clinical trial at King’s College London will investigate the use of cannabidiol (CBD) to treat symptoms of Parkinson's.
Staff have praised Louis Theroux documentary about mothers who develop mental ill health following the birth of their baby.
The Psychological Interventions Clinic for outpatients with Psychosis at South London and Maudsley has won an award.
Staff across our partnership were recognised at the Lammy Awards for their outstanding contribution to health and social care in Lambeth.
A psychiatric intensive care unit at South London and Maudsley has won a National Association of Psychiatric Intensive Care Units Award.
King’s College London research has found that cannabis extract cannabidiol can help reduce brain abnormalities in people with psychosis.
Researchers at King’s College London have carried out the largest neuroimaging study examining psychotic-like experiences in adolescents.
Researchers at King’s College London have found evidence of a link between autoimmune disorders and psychotic disorders.
South London and Maudsley has won Project of the Year at the Design in Mental Health Awards 2018 for their new sensory room.